Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domain-

AUH ECHDC2

5.09e-0545521.10.12.10
DomainCrontonase_C

AUH ECHDC2

8.47e-055552IPR014748
DomainEnoyl-CoA_hyd/isom_CS

AUH ECHDC2

2.36e-048552IPR018376
DomainENOYL_COA_HYDRATASE

AUH ECHDC2

3.77e-0410552PS00166
DomainCrotonase_core_superfam

AUH ECHDC2

1.13e-0317552IPR001753
DomainECH_1

AUH ECHDC2

1.13e-0317552PF00378
Domain-

AUH ECHDC2

1.72e-03215523.90.226.10
DomainClpP/crotonase-like_dom

AUH ECHDC2

1.72e-0321552IPR029045
Domain-

SYNJ2 SMPD2

2.64e-03265523.60.10.10
DomainExo_endo_phos

SYNJ2 SMPD2

2.64e-0326552PF03372
DomainEndo/exonuclease/phosphatase

SYNJ2 SMPD2

2.85e-0327552IPR005135
Pubmed

Hypoxic activation of ATR and the suppression of the initiation of DNA replication through cdc6 degradation.

ATR CDC6

2.55e-06256222179839
Pubmed

ATR (AT mutated Rad3 related) activity stabilizes Cdc6 and delays G2/M-phase entry during hydroxyurea-induced S-phase arrest of HeLa cells.

ATR CDC6

2.55e-06256219154794
Pubmed

A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.

PCSK5 PHAF1 USP6 LAT2 PTPRN2 GTPBP3 AHDC1 SERTAD1

5.66e-0660856816713569
Pubmed

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.

ATR CDC6

1.52e-05456228228262
Pubmed

CDC6 interaction with ATR regulates activation of a replication checkpoint in higher eukaryotic cells.

ATR CDC6

1.52e-05456220048340
Pubmed

Role of PCSK5 expression in mouse ovarian follicle development: identification of the inhibin α- and β-subunits as candidate substrates.

PCSK5 INHBB

1.52e-05456221408162
Pubmed

A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans.

SARM1 SLC46A1

1.14e-041056211386760
Pubmed

Intrinsic neural stem cell properties define brain hypersensitivity to genotoxic stress.

ATR PCNT

1.66e-041256235623353
Pubmed

Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels.

SARM1 SLC46A1

1.96e-041356225080503
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

LRIG3 TMEM221 ATR SARM1 B3GALT6 SLC46A1 TRIM47 MMP15

2.83e-04106156833845483
Pubmed

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry.

INHBB IDH3A

4.28e-041956212543931
Pubmed

Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression.

ATR CTSC

4.28e-041956236359803
Pubmed

Programmed cell senescence during mammalian embryonic development.

ATR PCNT

5.24e-042156224238962
Pubmed

Single nucleotide polymorphisms of matrix metalloproteinase 9 (MMP9) and tumor protein 73 (TP73) interact with Epstein-Barr virus in chronic lymphocytic leukemia: results from the European case-control study EpiLymph.

PHAF1 NLRP12 SARM1 CDC6

5.31e-0423156421048031
Pubmed

DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system.

ATR CDC6

5.76e-042256215707391
Pubmed

Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

SALL2 SYNJ2 PTPRN2

6.42e-041045639205841
Pubmed

Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.

PCSK5 INHBB LAMA2 MSLN

6.93e-0424856424006456
Pubmed

E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.

MICAL1 RNH1

9.37e-042856230277474
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

LRIG3 SYNJ2 LRP4 SMPD2 NUDT16L1 TMEM102

1.03e-0371956635337019
Pubmed

Feedback regulation of p38 activity via ATF2 is essential for survival of embryonic liver cells.

DUSP1 MAP3K6

1.08e-033056217699753
Pubmed

Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.

SYNJ2 PTPRN2 LRP4

1.22e-0313056312421765
Pubmed

Fine-mapping quantitative trait loci affecting murine external ear tissue regeneration in the LG/J by SM/J advanced intercross line.

KRT15 ATR

1.30e-033356224569637
Pubmed

Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.

ATR CDC6

1.38e-033456212791985
Pubmed

Tracing the origin of hair follicle stem cells.

KRT15 LRP4

1.46e-033556234108685
Cytoband19p13.11

TMEM221 GTPBP3 ANO8

1.01e-047356319p13.11
ToppCelldroplet-Liver-hepatocytes-3m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NLRP12 EBPL HAGH FITM1

4.12e-05153564d9e2c386875bc15e1e6e75dc7acf05c0dc8c306b
ToppCell10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue

LRIG3 SLC16A9 SLC46A1 MMP15

4.44e-051565649a897fc79c4fae94c5f2e9012d65297f9225e5e3
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

LRIG3 SALL2 INHBB LAMA2

5.65e-05166564f416d8a322f086c769659a9fab6b460a2d546ab1
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TMEM178A LAMA2 LRP4 GPR143

6.63e-05173564f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TMEM178A LAMA2 LRP4 GPR143

6.63e-05173564cbd65dd5b01cc959e3ccbc89330ddd0122296ea3
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-6|TCGA-Pancreas / Sample_Type by Project: Shred V9

TTYH1 TMEM221 ALKAL2 FITM1

6.78e-051745649ad13d4613c4f80bdd8033cc1ecf60eda7c0e6e5
ToppCell10x5'v1-week_17-19-Myeloid_DC-DC-DC3|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

TTYH1 RNH1 CTSC MSLN

8.25e-05183564c6cac433ea7a3d60728efdc7051e09e01bb3ade5
ToppCellLPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PCSK5 LAMA2 LRP4 GPR143

8.25e-0518356412daaea821e49bc94a01e2496331e92a80d27339
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PCSK5 LAMA2 LRP4 GPR143

8.60e-051855643b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TTYH1 LAMA2 TMPRSS5 MMP15

8.78e-051865646f88b68735d0f7c9904eb8413e6007910d556185
ToppCellwk_08-11-Epithelial-PNS-intermediate_Schwann|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

TTYH1 LAMA2 TMPRSS5 MMP15

9.15e-051885643f3a744b2615bf72f6119f26087099110c0d21fc
ToppCell10x5'v1-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

RNH1 CTSC IDH3A MSLN

9.53e-05190564d06800ec9f6065c1cc536ed99e8569732272a94f
ToppCell10x5'v1-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

RNH1 CTSC IDH3A MSLN

9.53e-05190564485073e831afebdb393c7f4b622504d43d1b778b
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

LRIG3 SLC16A9 TMEM178A MMP15

9.92e-051925648899d81306770adda893b5e146df1253971754c5
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

LRIG3 SLC16A9 TMEM178A MMP15

9.92e-051925645fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell10x3'2.3-week_14-16-Myeloid_DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

RNH1 CTSC IDH3A MSLN

1.01e-04193564c6633aca0eb4d699c4d3da3199b84bebd87e2d31
ToppCell10x5'v1-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

RNH1 CTSC IDH3A MSLN

1.01e-04193564bdbbfcbe339f23a88dfcc59d53c034bac1605b07
ToppCell10x5'v1-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

RNH1 CTSC IDH3A MSLN

1.01e-04193564acafe177cd05b2966f5fa26ea02f420f13f2cee5
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LAT2 CTSC DUSP1 MSLN

1.01e-04193564fc2eb6a7b4f1e687bf37e59e3cd52b14f99ffea4
ToppCell10x3'2.3-week_14-16-Myeloid_DC-DC|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

RNH1 CTSC IDH3A MSLN

1.01e-04193564a32791b4bdb7c5f2b4cc75b660321ab75c4fac9b
ToppCellfacs-Thymus-Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT15 PTPRN2 DUSP1 TRIM47

1.03e-04194564255d6eead8da740a942a5e7d554dbd895d736d1a
ToppCellfacs-Thymus-Epithelium-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT15 PTPRN2 DUSP1 TRIM47

1.05e-04195564cc89261bb091ef978bd73cffc68ccdd00a8786d1
ToppCellPBMC-Control-cDC_7|Control / Compartment, Disease Groups and Clusters

RNH1 SYNJ2 EBPL SERTAD1

1.05e-04195564c8f9f2911c2f963b5d1336fbb5567bfc7f3e737b
ToppCellNon-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster

TTYH1 LRIG3 INHBB LRP4

1.10e-0419756461749ccafeb938c310cff1de5ff924a1c794325a
ToppCellNon-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster

TTYH1 LRIG3 INHBB LRP4

1.10e-041975649d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell356C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

PCSK5 LAT2 CTSC SERTAD1

1.10e-04197564c7cd7960e8f022b1db49485ff153675827efa35e
ToppCelldroplet-Skin-nan-21m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KRT15 DUSP1 TRIM47 SERTAD1

1.12e-04198564db9507386cdccbde7389a77667dbd0e5550ed4df
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PCSK5 LAMA2 LRP4 GPR143

1.14e-0419956438cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCellBasal-basal-10|World / Class top

KRT15 RNH1 DUSP1 TRIM47

1.14e-041995644fadfc58102b21bf9db9d0092f3437aa78fddd99
ToppCellTracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations

LRIG3 KRT15 SYNJ2 PTPRN2

1.16e-04200564682960e28542a3d6c119047cd0131941932cfdea
ToppCell5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TTYH1 LAMA2 TMPRSS5 MMP15

1.16e-04200564363a8cebf2ace820661bcb87c7941f6671f8e5f3
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LRIG3 KRT15 GTPBP3 MMP15

1.16e-0420056468b0f987c4fb8078675475f4f1e71302f832ef69
ToppCellParenchymal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Duct|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LRIG3 KRT15 GTPBP3 MMP15

1.16e-042005641b527bebbca1ef8c52449e40beb9358e37494e04
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PCSK5 LAMA2 LRP4 GPR143

1.16e-0420056409537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCellLPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type

PCSK5 LAMA2 LRP4 GPR143

1.16e-04200564a9ff3210127000b3dd9e97136163c98c2b0817d7
Diseaselevel of t-SNARE domain-containing protein 1 in blood serum

SARM1 SLC46A1

3.17e-062532OBA_2044401
Diseaselevel of complement C1q-like protein 2 in blood serum

SARM1 SLC46A1

3.17e-062532OBA_2040846
DiseaseChronic myeloproliferative disorder

ATR CDC6 PCNT

5.20e-0619533C1292778
DiseaseSeckel syndrome

ATR CDC6 PCNT

8.23e-0622533C0265202
Diseasealpha-(1,3)-fucosyltransferase 9 measurement

NLRP12 SARM1

9.49e-063532EFO_0801367
DiseaseNHP2-like protein 1 measurement

NLRP12 SARM1

9.49e-063532EFO_0801840
DiseaseSeckel syndrome 1

ATR PCNT

9.49e-063532C4551474
Diseasehistone deacetylase complex subunit SAP18 measurement

NLRP12 SARM1

9.49e-063532EFO_0801680
DiseaseUMP-CMP kinase measurement

SARM1 SLC46A1

9.49e-063532EFO_0008313
Diseasepro-FMRFamide-related neuropeptide FF measurement

NLRP12 SARM1

1.89e-054532EFO_0801911
Diseasemesothelin measurement

SARM1 MSLN

1.89e-054532EFO_0020565
Diseasearf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 measurement

NLRP12 SARM1

1.89e-054532EFO_0803306
Diseaseserine/threonine-protein kinase 17B measurement

NLRP12 SARM1

3.15e-055532EFO_0008281
Disease17-beta-hydroxysteroid dehydrogenase 14 measurement

SARM1 SLC46A1

3.15e-055532EFO_0802231
Diseasen-acetyltransferase 14 measurement

NLRP12 SARM1

3.15e-055532EFO_0801819
Diseaselysozyme-like protein 2 measurement

NLRP12 SARM1

3.15e-055532EFO_0801779
Diseaselow-density lipoprotein receptor-related protein 1, soluble measurement

NLRP12 SARM1

3.15e-055532EFO_0801772
Diseaseprotein NDRG4 measurement

NLRP12 SARM1

4.73e-056532EFO_0801954
Diseasenischarin measurement

NLRP12 SARM1

4.73e-056532EFO_0801841
Diseasen-acetylserotonin O-methyltransferase-like protein measurement

NLRP12 SARM1

4.73e-056532EFO_0801818
Diseaseprotein S100-A12 measurement

NLRP12 SARM1

6.61e-057532EFO_0010925
Diseaserho GTPase-activating protein 30 measurement

NLRP12 SARM1

6.61e-057532EFO_0802012
Diseaseribonucleoside-diphosphate reductase subunit M2 B measurement

NLRP12 SARM1

6.61e-057532EFO_0802022
Diseaseglutathione s-transferase p measurement

NLRP12 SARM1

6.61e-057532EFO_0020410
Diseasebreast cancer anti-estrogen resistance protein 3 measurement

NLRP12 SARM1

8.80e-058532EFO_0008040
Diseasecalcium/calmodulin-dependent protein kinase type 1D measurement

SARM1 SLC46A1

8.80e-058532EFO_0008063
Diseasesialic acid-binding Ig-like lectin 12 measurement

NLRP12 SARM1

8.80e-058532EFO_0802066
Diseasetumor necrosis factor receptor superfamily member 16 measurement

NLRP12 SARM1

1.13e-049532EFO_0802168
Diseaseleucine-rich repeat serine/threonine-protein kinase 2 measurement

NLRP12 SARM1

1.13e-049532EFO_0021876
Diseasetumor necrosis factor ligand superfamily member 14 measurement

NLRP12 SARM1

1.13e-049532EFO_0010613
DiseaseWNT1-inducible-signaling pathway protein 1 measurement

SARM1 SLC46A1

1.41e-0410532EFO_0008321
Diseaseserine protease 27 measurement

SARM1 SLC46A1

2.07e-0412532EFO_0008280
Diseasesemaphorin-3A measurement

SARM1 SLC46A1

3.27e-0415532EFO_0008278
Diseasevitronectin measurement

SARM1 SLC46A1

7.82e-0423532EFO_0021843
Diseasetotal brain volume change measurement, age at assessment

PTPRN2 CTSC

9.25e-0425532EFO_0008007, EFO_0021504
Diseaseinterleukin 5 measurement

SARM1 SLC46A1

1.16e-0328532EFO_0008185
Diseaserefractive error, self reported educational attainment

LAMA2 ALKAL2

1.71e-0334532EFO_0004784, MONDO_0004892

Protein segments in the cluster

PeptideGeneStartEntry
LRGLCEDALEGLLFL

TTYH1

381

Q9H313
ILLGCGLDAFLGLAT

SLC4A9

671

Q96Q91
RAALGLGTLALCGAA

B3GALT6

11

Q96L58
LSCLTGEGLDGLLEA

GTPBP3

396

Q969Y2
GLLSAEAGRDDLLGL

APBA3

101

O96018
CGGLAELLLRYGARA

ASB16

296

Q96NS5
GLLADFLGRTEAACL

AHDC1

1486

Q5TGY3
EGEEGGLLDCGLRLK

ANO8

601

Q9HCE9
RLGCLLEEGLCGASE

PTPRN2

36

Q92932
GLDGCLLIVGALALN

SLC16A9

166

Q7RTY1
LGRILCALLGDFGGL

SLC46A1

146

Q96NT5
LKLRGLGLADLGCLG

LRRC61

36

Q9BV99
LGLADLGCLGECLGL

LRRC61

41

Q9BV99
AGLGLLLCAVLGRAG

LRIG3

11

Q6UXM1
GLALGGGLELALACD

AUH

181

Q13825
GLLGRRSLAALGAAC

HAGH

6

Q16775
GRALGAACLLLLAAG

INHBB

6

P09529
LLGCLGLGVAAEDAE

MMP15

36

P51511
ALGGGLELALACDLR

ECHDC2

136

Q86YB7
RVLCGDAGLLRGLAD

MAP3K6

186

O95382
GRLDLLCVLALLGGC

PCSK5

11

Q92824
LRGECELGTSGALLL

LURAP1

31

Q96LR2
ELGAEAGGSLLLCAA

EBPL

6

Q9BY08
LLAAGCALGLRLGRG

EBPL

21

Q9BY08
KHGARLLLGLVGDCL

MICAL1

381

Q8TDZ2
DECTGLLLGDLARLE

LAMA2

1576

P24043
LLSEADVRALGGLAC

MSLN

176

Q13421
GLIGGLEAQLSELRC

KRT15

366

P19012
RVGLCLDDAGAGLAL

PCNT

1186

O95613
LLLALLCVLAAGGGA

SMPD2

336

O60906
RLLCGECLGELGAID

ATR

1351

Q13535
GDILSDLCAGLIGGL

IDH3A

256

P50213
GGLRALLGERAAQCL

DUSP1

11

P28562
LGAGARIQALLGCLL

FITM1

11

A5D6W6
ALCLGSGGLRLALGL

GPR143

31

P51810
ALLLLLSGDGAVRCD

CTSC

11

P53634
CLSLSGLLEARGILG

CDC6

506

Q99741
GLLAAQCLGAARGLE

SALL2

326

Q9Y467
IGGLCRGDLSLSLAL

LAT2

156

Q9GZY6
LLALRLALEDGCGPG

TRIM47

336

Q96LD4
SGRGGAALLCLSALL

TMEM132E

6

Q6IEE7
GLRLLGRLGAEGDCS

SYNJ2

6

O15056
RSLLGLGGLDAECGR

TMEM178A

91

Q8NBL3
RLAAGGGCLLLAALC

SFT2D3

76

Q587I9
DLLGPATGCLLDDGL

SERTAD1

156

Q9UHV2
RLLAAGCGPGLLADA

PHAF1

216

Q9BSU1
LLGRDCALGRAEAAG

ALKAL2

61

Q6UX46
LLGIDLLCGNGCDDL

WDR47

226

O94967
LCDAIRLDGGLDLLL

SARM1

116

Q6SZW1
DGLNRVLGLGLGCLR

NUDT16L1

76

Q9BRJ7
VLGLGLGCLRLTEAD

NUDT16L1

81

Q9BRJ7
GACCLGLLDELGRVL

TMEM102

431

Q8N9M5
RRGCAVLGALGLLAG

TMPRSS5

46

Q9H3S3
LAGNELGDEGARLLC

RNH1

291

P13489
LALLCAVGALADGRE

nan

11

A8MTW9
LLLAALCGHLGAELA

TMEM221

86

A6NGB7
LDFGGILEGELDLCR

VWA3B

146

Q502W6
GCLLRNLIDGISLGL

USP6

266

P35125
GALLLGALLCAHGLA

LRP4

6

O75096
GNALEDLGLRLLCQG

NLRP12

836

P59046
LGDLGVLLLCEGLRH

NLRP12

896

P59046